Notice of Q3 2019 Trading Update
Updated : 09:01
UDG Healthcare plc
Notice of Q3 2019 Trading Update
30 July 2019: UDG Healthcare plc ("UDG Healthcare" or "Group"), a leading international healthcare services provider, will issue a trading update for the third quarter to 30 June 2019 at 7.00a.m. (BST) on Wednesday, 7 August 2019.
The Company will also host a conference call for investors and analysts at 8.00am (BST) on Wednesday, 7 August 2019 to discuss the statement. The dial-in details are as follows:
Standard International Access | +44 (0) 20 3037 9299 |
UK Toll Free | 0800 368 2555 |
Ireland Toll Free | 1 800 930 488 |
Ireland local | +353 (0) 1 436 0959 |
Password | UDG Healthcare |
A playback facility will be available for seven days on +44 (0) 203 451 9993. The access code for the replay will be 9471508#.
For further information, please contact:
Keith Byrne
Head of Investor Relations, Strategy & Corporate Communications
UDG Healthcare plc
Tel: +353-1-468-9000
Lisa Kavanagh / Jack Hickey / Ella Morris
Powerscourt
Tel: +44-207-250-1446
Email: udghealthcare@powerscourt-group.com
About UDG Healthcare plc:
UDG Healthcare plc (LON: UDG) is a leading international partner of choice delivering advisory, communication, commercial, clinical and packaging services to the healthcare industry, employing over 9,000 people with operations in 26 countries and delivering services in over 50 countries.
UDG Healthcare plc operates across two divisions: Ashfield and Sharp.
Ashfield is a global leader in advisory, communication, commercial and clinical services for the pharmaceutical and healthcare industries. It focuses on supporting healthcare professionals and patients at all stages of the product life cycle. The division provides field and contact centre sales teams, healthcare communications, patient support, audit, advisory, medical information and event management services to over 300 healthcare companies.
Sharp is a global leader in contract commercial packaging and clinical trial packaging services for the pharmaceutical and healthcare industries, operating from state-of the-art facilities in the US and Europe.
The company is listed on the London Stock Exchange and is a constituent of the FTSE 250. For more information, please go to: www.udghealthcare.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.